Clinical Trials in San Francisco

Showing 2841-2860 of 12,991 trials

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

NCT01734512

This is an open label study of everolimus in children with recurrent or progressive low-grade glioma.

Pediatric Recurrent Progressive Low-grade GliomasPediatric Progressive Low-grade Gliomas

University of California, San Francisco65 participantsStarted Dec 2012

Los Angeles, California, United States • Los Angeles, California, United States • Oakland, California, United States +15 more locations

TERMINATEDPhase 1/2< 1 mile

Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

NCT03838367

This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplatin in Patients with CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC). Study population will consist of patients with CCR5-positive, locally advanced or metastatic triple-negative breast cancer (mTNBC) who are naïve to chemotherapy in metastatic setting but have been exposed to anthracyclines and taxane in neoadjuvant and adjuvant settings (first-line).

Triple Negative Breast Neoplasms

CytoDyn, Inc.10 participantsStarted Apr 2019

San Francisco, California, United States • Chicago, Illinois, United States

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

Find Trials by Condition in San Francisco

Continuous Glucose Monitoring System Feasibility in Youth With T2D

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

International Rare Brain Tumor Registry

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women

OCS DCD Heart + CAP Continued Follow-Up

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

Gene Therapy for Pyruvate Kinase Deficiency (PKD)

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Skin Reactions Related to Thoracic Implantable Chamber Dressings